Dotmatics Associate VP, Industry Principal of Biologics, Christian O. was featured on MarTech Edge's Tuesdays with Trailblazers podcast recently for a discussion on AI and how Dotmatics supports scientific R&D. Watch the full podcast now: https://lnkd.in/eG8r5Bkt
Dotmatics’ Post
More Relevant Posts
-
Helping Scientists Develop and Manufacture Biologics & CTO on Demand | Bioprocess CMC Development | Project Management | Business Strategy
What's your top strategy for crafting an effective CMC roadmap? PS: if you don't know where to start, listen to my recent conversation with Matthias Müllner, CEO and Co-founder of bespark*bio.
Hey out there! Interested to understand why a solid CMC roadmap is key for successful product development? Don’t miss our CEO Matthias Müllner discussing with David Brühlmann, PhD in the latest episode of the Smart Biotech Scientist podcast. Tune in now at SmartBiotechScientist.com! #viralvectors, #genetherapy, #cellandgenetherapy, #immunooncology, #bioprocessing, #processdevelopment, #biotech, #CMC
-
inThought Research's Ben Weintraub and Doug Foster discuss how AI can help decision making in pharma on Dr. Andree Bates' latest podcast episode. Take a listen here https://lnkd.in/e2Z-rRJm #AI #artificialintelligence #pharma #biotech
-
-
What did your colleagues say when you told them you were transitioning to pharma? Did they say you were going to the "dark side"? In today's "Elevate" podcast episode, we explore the origins of negative opinions of the pharmaceutical industry, and whether a for-profit model can support both innovation and society's best interests in: "Technology Fears & Scapegoats: The Origins and Consequences of Pharmaceutical Industry Myths" with expert speaker Rob Atkinson, author of "Technology Fears and Scapegoats: 40 Myths About Privacy, Jobs, AI, and Today’s Innovation Economy"! Listen to this episode HERE: https://lnkd.in/gcnQFAgW #MedicalAffairs #MedAffairs #podcast #jointhemovement
-
Check out our recent podcast episode: A deep dive into expression approaches for #biotherapeutics 🎧 Experts from Lonza and DTU - Technical University of Denmark share the key considerations of selecting an expression format during #biotherapeutic development 💬 Listen here! https://bit.ly/3yenUSi
CHO Talks: A deep dive into expression approaches for biotherapeutics
themedicinemaker.com
-
Check out our recent podcast episode: A deep dive into expression approaches for #biotherapeutics 🎧 Experts from Lonza and DTU - Technical University of Denmark share the key considerations of selecting an expression format during #biotherapeutic development 💬 Listen here! https://bit.ly/3yenUSi
CHO Talks: A deep dive into expression approaches for biotherapeutics
themedicinemaker.com
-
Check out our recent podcast episode: A deep dive into expression approaches for #biotherapeutics 🎧 Experts from Lonza and DTU - Technical University of Denmark share the key considerations of selecting an expression format during #biotherapeutic development 💬 Listen here! https://bit.ly/3yenUSi
CHO Talks: A deep dive into expression approaches for biotherapeutics
themedicinemaker.com
-
In the world of #genetherapy, collaboration matters. 🤝 Jennifer Chadwick, Chief Scientific Officer at #ProtaGene, discusses why finding the right partner is critical to #pharma organizations in this podcast episode with The Business Journals. 🎙 Check it out here ⬇️ https://bit.ly/4appS0y #biopharma #biotech
-
-
Entrepreneur | Helping Safety Critical B2B companies to Grow | Business Development | Growth Hacker | Podcast Host |
What a great discussion with you Mark Rutledge. Thanks for taking the time discussing about how organ on a chip technologies are accelerating drug development processes. Link is below for anyone interested
🎙️ New episode from Modern LifeScience Podcast! 🚀 We're thrilled to present an insightful interview featuring Mark Rutledge, CEO of World Precision Instruments, LLC. (WPI), hosted by Jeremy DEROSIER from Cartier Development. 🌟 Join us as Mark Rutledge discusses WPI's remarkable journey and strategic vision in the life sciences and diagnostics space. Learn about the potential of organ-on-a-chip technology in revolutionizing drug discovery and development. Gain valuable insights into the future of pharmaceutical development and the role of this technology in driving cost-effectiveness and faster time-to-market for new drugs development. 🧬💊 🔊 Listen to the full podcast episode on our Offcial Website, Apple Podcast, Youtube, Spotify: https://lnkd.in/gAWKDnqq Special thanks to Mark Rutledge, CEO of WPI for his invaluable contributions to this engaging discussion! 👏 #LifeSciences #Diagnostics #Innovation #DrugDiscovery #PodcastInterview #organonachip #drugdevelopment #drugdiscovery #ModernLifescience
-
Combating some of the world's most significant health issues requires innovative research, development, and funding, which is why specific medical interventions such as complex biologics and advanced therapeutic strategies have entered into the latest episode of Bio Banter. Together, host Michael Margolis, R.Ph., and featured guest Daniel Parisotto, Ph.D., examine private biotech market activity, comparing 2023 numbers to pre-pandemic metrics as well as the outlook and trends for the next several months. This podcast is available on all major podcast platforms: https://bit.ly/3RsiM4C #Biotech #Therapeutics #Oppenheimer #LetsTalkFuture
Bio Banter – Vital Signs Robust on Private Side
oppenheimer.com
-
Managing Director-Investments Private Client Division Branch Manager Pacific Northwest at Oppenheimer & Co. Inc.
Combating some of the world's most significant health issues requires innovative research, development, and funding, which is why specific medical interventions such as complex biologics and advanced therapeutic strategies have entered into the latest episode of Bio Banter. Together, host Michael Margolis, R.Ph., and featured guest Daniel Parisotto, Ph.D., examine private biotech market activity, comparing 2023 numbers to pre-pandemic metrics as well as the outlook and trends for the next several months. This podcast is available on all major podcast platforms: https://bit.ly/3Lxiohh #Biotech #Therapeutics #Oppenheimer #LetsTalkFuture
Bio Banter – Vital Signs Robust on Private Side
oppenheimer.com
